BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31756389)

  • 1. Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial.
    Slee A; Saksena S
    Am Heart J; 2020 Feb; 220():1-11. PubMed ID: 31756389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.
    Inciardi RM; Giugliano RP; Claggett B; Gupta DK; Chandra A; Ruff CT; Antman EM; Mercuri MF; Grosso MA; Braunwald E; Solomon SD;
    Eur J Heart Fail; 2019 Dec; 21(12):1571-1579. PubMed ID: 31777160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
    Kao DP; Davis G; Aleong R; O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Murphy GA; Sauer W; Bristow MR
    Eur J Heart Fail; 2013 Mar; 15(3):324-33. PubMed ID: 23223178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.
    Ullah W; Ling LH; Prabhu S; Lee G; Kistler P; Finlay MC; Earley MJ; Sporton S; Bashir Y; Betts TR; Rajappan K; Thomas G; Duncan E; Staniforth A; Mann I; Chow A; Lambiase P; Schilling RJ; Hunter RJ
    Europace; 2016 May; 18(5):679-86. PubMed ID: 26843584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design.
    Parkash R; Wells G; Rouleau J; Talajic M; Essebag V; Skanes A; Wilton SB; Verma A; Healey JS; Tang AS
    Am Heart J; 2021 Apr; 234():90-100. PubMed ID: 33472052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter Ablation for Atrial Fibrillation with Heart Failure.
    Marrouche NF; Brachmann J; Andresen D; Siebels J; Boersma L; Jordaens L; Merkely B; Pokushalov E; Sanders P; Proff J; Schunkert H; Christ H; Vogt J; Bänsch D;
    N Engl J Med; 2018 Feb; 378(5):417-427. PubMed ID: 29385358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation.
    Su HM; Lin TH; Hsu PC; Lee WH; Chu CY; Lee CS; Voon WC; Lai WT; Sheu SH
    Heart; 2013 Nov; 99(21):1588-96. PubMed ID: 24014280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction.
    Sartipy U; Savarese G; Dahlström U; Fu M; Lund LH
    Eur J Heart Fail; 2019 Apr; 21(4):471-479. PubMed ID: 30698317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
    Europace; 2023 May; 25(5):. PubMed ID: 37078691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Shah J; Morales G; Leung SW; Fornwalt B; Bailey AL; Ziada K; Sorrell VL; Zegarra MM; Thompson J; Hosn NA; Campbell CL; Gurley J; Anaya P; Booth DC; Di Biase L; Natale A; Smyth S; Moliterno DJ; Elayi CS;
    Europace; 2014 Jun; 16(6):803-11. PubMed ID: 24368753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.